It is great to see that another PARP inhibitor has been licensed for use in the UK but it is only effective for people with the BRCA mutation or for those without that mutation, if their cancer is responding to platinum based chemotherapy.
Does anyone know what is available to those of us without the BRCA mutation and whose cancer is not currently responding to platinum based drugs? My oncologist has told me it will be weekly paclitaxol, but not for how long , nor what else may be available.
Sometimes I feel like a child who has been told she has to leave the party before all the games have been played, and with no-one to appeal to.
Diane